Home/Filings/4/0001104659-23-041752
4//SEC Filing

Granfield Christine 4

Accession 0001104659-23-041752

CIK 0001509745other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 8:15 PM ET

Size

5.8 KB

Accession

0001104659-23-041752

Insider Transaction Report

Form 4
Period: 2023-03-31
Granfield Christine
VP, Head of Reg Affairs/Qual
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2023-03-31+500,000500,000 total
    Exercise: $0.34Exp: 2033-03-31Common Stock (500,000 underlying)
Footnotes (1)
  • [F1]The Option was granted pursuant to Leap's 2016 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on the one month anniversary of March 31, 2023, the Vesting Start Date.

Issuer

LEAP THERAPEUTICS, INC.

CIK 0001509745

Entity typeother

Related Parties

1
  • filerCIK 0001822190

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 8:15 PM ET
Size
5.8 KB